drugset / Trial / NCT05641311
Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The main purpose of the study is to confirm how long ALXN1840 stays in the body of Japanese and non-Japanese healthy participants (that is, pharmacokinetic \[PK\] profile).
Timeline
- Start
- 2019-02-20
- Primary completion
- 2019-05-02
- Completion
- 2019-05-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TIOMOLIBDATE CHOLINE | Small molecule | 15 mg | Oral |
| Subject | TIOMOLIBDATE CHOLINE | Small molecule | 60 mg | Oral |